Carlisle Companies Incorporated (CSL)

Debt-to-assets ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Long-term debt US$ in thousands
Total assets US$ in thousands 5,816,600 6,478,400 6,728,300 6,645,900 6,620,000 6,816,000 7,176,200 7,115,400 7,222,000 7,732,000 7,577,700 7,323,000 7,246,800 7,074,600 5,839,300 5,752,200 5,866,400 5,800,000 5,808,300 6,297,600
Debt-to-assets ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2024 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $5,816,600K
= 0.00

The debt-to-assets ratio for Carlisle Companies Incorporated has consistently remained at 0.00% from March 31, 2020, through December 31, 2024. This indicates that the company has not taken on any debt that is reflected on its balance sheet during this period, in relation to its total assets. A debt-to-assets ratio of 0.00% typically suggests that the company is primarily funded through equity rather than debt, which can be seen as a positive indicator of financial stability and lower financial risk. It indicates a strong financial position and suggests that the company may have sufficient liquidity and solvency to meet its financial obligations without relying heavily on borrowing.


Peer comparison

Dec 31, 2024

Company name
Symbol
Debt-to-assets ratio
Carlisle Companies Incorporated
CSL
0.00
West Pharmaceutical Services Inc
WST
0.00